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Abstract
CD4+ T cells have been shown to be essential for vaccine-induced protection against Heli-
cobacter pylori infection. However, the effector mechanisms leading to reductions in the
gastric bacterial loads of vaccinated mice remain unclear. We have investigated the func-
tion of IFN-γ and IL-17A for vaccine-induced protection and inflammation (gastritis) using
IFN-γ-gene-knockout (IFN-γ-/-) mice, after sublingual or intragastric immunization with H.
pylori lysate antigens and cholera toxin. Bacteria were enumerated in the stomachs of mice
and related to the gastritis score and cellular immune responses. We report that sublingually
and intragastrically immunized IFN-γ-/- mice had significantly reduced bacterial loads similar
to immunized wild-type mice compared to respective unimmunized infection controls. The
reduction in bacterial loads in sublingually and intragastrically immunized IFN-γ-/- mice was
associated with significantly higher levels of IL-17A in stomach extracts and lower gastritis
scores compared with immunized wild-type mice. To study the role of IL-17A for vaccine-
induced protection in sublingually immunized IFN-γ-/- mice, IL-17A was neutralized in vivo at
the time of infection. Remarkably, the neutralization of IL-17A in sublingually immunized
IFN-γ-/- mice completely abolished protection against H. pylori infection and the mild gastri-
tis. In summary, our results suggest that IFN-γ responses in the stomach of sublingually
immunized mice promote vaccine-induced gastritis, after infection with H. pylori but that IL-
17A primarily functions to reduce the bacterial load.
Introduction
Helicobacter pylori infection in the stomach is characterised by gastritis with both active (neu-
trophils) and chronic (T and B cells) components [1]. Although a robust H. pylori-specific
immune response can be detected in the circulation and stomach of infected individuals, it is
insufficient to eradicate the infection [2]. Furthermore, epidemiological studies have shown
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that the immune response to a previous infection with H. pylori does not protect against rein-
fection by subjects in whom the infection has been eradicated by antibiotic therapy [3–5]. Vac-
cination with H. pylori antigens and an adjuvant can potentially enhance the infection-induced
immune responses, resulting in a reduction in gastric bacterial loads [6, 7] and also protect
against reinfections [3] in animal models.
Indeed, studies in a mouse model ofH. pylori infection have demonstrated that prophylactic
sublingual (under the tongue; SL) [8] or intragastric (IG) [5] immunization with H. pylori anti-
gens and the mucosal adjuvant cholera toxin (CT) reduced the gastric bacterial loads and that
this phenomenon was dependent on the presence of CD4+ T cells rather than antibodies [9–
11]. Furthermore, the immunization polarized the CD4+ T helper cells to produce enhanced
interferon-γ (IFN-γ) and interleukin-17A (IL-17A) in the stomach when compared with unim-
munized mice [8, 12]. However, in spite of a strong influx of CD4+ T cells, B cells, eosinophils,
mast cells and dendritic cells in the stomach of vaccinated mice post-challenge which manifests
as severe gastritis, the infection is rarely eradicated [12–14]. Clearly, we need to improve our
understanding of the differences between infection and vaccination induced gastritis and the
mechanisms by which this extra cellular bacterium can be eliminated.
Previous reports on the role of IFN-γ in the vaccine-induced protection against H. pylori
infection have been contradictory. Using IFN-γ-/- mice, one study reported the complete
dependence on IFN-γ for protection after IG immunization at two weeks post challenge [15],
whereas another study showed no dependence of IFN-γ for protection after intranasal (IN)
immunization at four weeks post challenge [16]. The same antigens (H. pylori lysate antigens)
and mucosal adjuvant (cholera toxin; CT) were used in both studies. Furthermore, the studies
demonstrated that post-immunization gastritis was dampened in intragastrically but not intra-
nasally immunized IFN-γ-/- mice, although the differing times after H. pylori challenge may
also play a role [15, 16]. We have previously shown that the in vivo neutralization of IFN-γ at
the time of challenge in wild-type sublingually immunized mice did not abrogate protection
against H. pylori infection. The effect of this treatment on post-immunization gastritis, how-
ever, was not studied [17]. Thus, the importance of IFN-γ in sublingually vaccinated mice for
protection against H. pylori infection and/or post-immunization gastritis is currently
unknown.
The contradictory reports on the role of IFN-γ in the protection againstH. pylori infection
using knockout mice might be explained by the presence of IL-17A in the stomach [8, 17–19].
As described previously, IL-17A has been detected in the stomach of wild-type vaccinated mice
[17–19] and in H. pylori-infected individuals [20]. Inflammatory cytokines IL-1β, TGF-β, IL-6
and IL-23, which promote IL-17A secretion from CD4+ T cells (Th17 differentiation), have all
been shown to be enhanced in the stomachs of H pylori-infected individuals [20]. Additionally,
the vaccine-induced protection against H. pylori infection in mice was associated with an
increase in IL-17A; presumably this mediates the recruitment of neutrophils by inducing che-
mokine secretion in various cell populations. IL-17A and IL-22 can also induce the secretion of
antimicrobial agents like β-defensins, lactotransferrin and lipocalin-2 from epithelial cells and
neutrophils [21, 22]. We have previously reported that in vivo neutralization of IL-17A abol-
ished protection in immunized WTmice [17]. Further, Delyria et al. showed that neutrophils
were required for protection [17, 19]. These reports support a critical role for IL-17A in protec-
tive mechanisms.
The aim of the current study was to define the function of IFN-γ and IL-17A in the vaccine-
induced protection againstH. pylori infection and post-immunization gastritis after SL immu-
nization. We report that both IFN-γ-/- and wild-type mice immunized by the SL or IG route
show a significant reduction in the gastric bacterial loads compared to unimmunized controls.
Immunized IFN-γ-/- mice had a significantly elevated IL-17A secretion in the stomach, and
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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lower gastritis scores compared with immunized wild-type mice. The role of IL-17A in protec-
tion was further illustrated by the observation that in vivo neutralization of IL-17A in sublin-
gually immunized IFN-γ-/- mice abrogated the protection againstH. pylori infection. We
conclude that IL-17A rather than IFN-γ can be important for the reductions inH. pylori colo-
nization in the stomach of sublingually immunized mice.
Materials and Methods
Animals
Six-to-eight-week-old, specific-pathogen-free, female C57BL/6 wild-type mice were purchased
from Taconic (Denmark). Age-matched IFN-γ-deficient (IFN-γ-/-) mice on a C57BL/6 back-
ground [23] were bred at the Laboratory for Experimental Biomedicine (EBM), University of
Gothenburg, and all mice were housed in microisolators for the duration of the study. This
study was carried out in strict accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the Swedish Board of Agriculture. The study was approved
by the government animal ethics committee (Gothenburg; permit Number: 273/2011). All
immunizations and infections were performed under anaesthesia (Isoflurane; Abbott Scandi-
navia AB, Solna, Sweden), and all efforts were made to minimize suffering.
Cultivation of H. pylori SS1 used for infection
TheH. pylori bacterial strain SS1 was cultured on Columbia iso agar plates for 3 days at 37°C
under microaerophilic conditions and then transferred to liquid broth before the infection of
mice, as previously described [8]. The optical density of the bacteria was adjusted to 1.5, corre-
sponding to an infectious dose of approximately 2.5 x 109 viable bacteria/ml [5].
Preparation of H. pylori antigens
TheH. pylori lysate antigens from the strain Hel 305 (CagA+, VacA+) was prepared as previ-
ously described in detail in [8, 24]. The prepared antigen was aliquoted and stored at -70°C.
Aliquots of H. pylori lysate antigens for use in SL immunizations were freeze-dried and recon-
stituted to a protein concentration of 20 mg/ml to reduce the volume used for the immuniza-
tions. The same dose of antigen was used for both IG and SL immunizations. TheH. pylori
membrane protein (MP) antigen from strain Hel 305 (CagA+, VacA+) was prepared as previ-
ously described [25]. The antigen preparations were aliquoted and stored at -70°C until needed
to coat the ELISA plates for the detection of serum antibody titres.
Immunization and infection with H. pylori and neutralizing antibody
treatment
Lyophilized CT from Vibrio cholerae (Sigma Aldrich, St. Louis, MO) was reconstituted in
sterile distilled water to a concentration of 1 mg/ml. Groups of mice were immunized sublin-
gually or intragastrically two times at a bi-weekly interval with 200 μg ofH. pylori lysate
antigens together with 10 μg of CT on each occasion. The immunizations were administered
under deep anaesthesia (Isoflurane) by carefully placing 10 μl ofH. pylori lysate antigens recon-
stituted in CT without bicarbonate buffer through a micropipette under the tongue (SL route)
or by placing 300 μl of H. pylori lysate antigens together with CT in 3% sodium bicarbonate
buffer directly into the stomach using a blunt feeding needle (IG route). Two weeks after the
last immunization, the mice were challenged intragastrically with ~1 x 109 live H. pylori SS1
bacteria. In some experiments, the neutralizing IL-17A antibody clone JL7.1D10 (rat IgG)
(Merck Research Labs, Palo Alto, CA) [26] was injected intraperitoneally on days 5, 8 and 11
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post-challenge into sublingually immunized and unimmunized IFN-γ-/- mice [17]. Purified rat
IgG antibody (Sigma) was used as an isotype control.
Quantitative culture of H. pylori from the stomach
Two-three weeks post-infection, the mice were euthanized by an overdose of anaesthesia (Iso-
flurane) followed by cervical dislocation. The stomach was collected and the number of bacte-
ria/stomach was determined by quantitative culture [27]. Briefly, one half of each stomach was
homogenized in brucella broth using a tissue homogenizer (Ultra Turrax, IKA Laboratory
Technologies, Staufen, Germany) and dilutions of the homogenates were plated on blood skir-
row agar plates (BD (Becton Dickinson Biosciences), San Diego, CA). After 7 days of incuba-
tion at 37°C under microaerophilic conditions, H. pylori colonies were counted. The fold-
change in bacterial counts was calculated as the ratio of the mean Log10 number of bacteria in
the infected control mice to the Log10 number of bacteria in individual vaccinated mice.
Serum antibody responses
Blood was collected from the axillary plexus immediately before the mice were sacrificed.
Serum antibody titres were determined by enzyme-linked immunosorbent assay (ELISA) as
previously described [8]. Briefly, ELISA plates were coated with the membrane antigen prepa-
ration of H. pylori strain Hel 305 (MP Hel 305) and left overnight at room temperature. Bound
IgG antibodies in sera were detected using horseradish peroxidase (HRP)-coupled goat anti-
mouse IgG (Jackson Immuno Research, West Grove, PA) secondary antibodies and the reac-
tion with substrate o-phenylenediamine dihydrochloride (OPD), added together with H2O2.
The enzymatic reaction was then stopped by adding 1 M sulfuric acid, and the absorbance at
490 nm was then measured using a spectrophotometer. The antibody titers are defined as the
reciprocal serum dilution giving an absorbance of 0.4 above the background.
Cellular immune responses
Single-cell lymphocyte suspensions were prepared from the spleens and mesenteric lymph
nodes (MLN) of the different groups of mice. Briefly, cells were seeded (2 x 105 cells per well)
in the presence or absence of boiled H. pylori strain Hel 305 lysate antigens (4 μg/ml) and cul-
tured for 72 hours in Iscove’s medium (Biochrome, Berlin, Germany) supplemented with 10%
heat-inactivated foetal calf serum (Sigma), 50 μM 2-mercaptoethanol (Sigma), 1 mM L-gluta-
mine (Biochrome) and 50 μg/ml gentamicin (Sigma) (Iscove’s complete medium) at 37°C in a
5% CO2 atmosphere. Supernatants were collected and stored at -70°C for subsequent cytokine
analysis. The proliferation of the cells was determined as previously described [25]. Cells were
pulsed with 1 μCi of [3H] thymidine (Amersham Bioscience, Buckinghamshire, United King-
dom) for the last 6 to 8 h of culture. The cellular DNA was collected with a cell harvester (Ska-
tron) on glass fiber filters (Wallac) and assayed for 3H incorporation using a liquid scintillation
counter (Beckman, LKB, Bromma, Sweden).
Measurement of IFN-γ and IL-17A in saponin extracts of stomach tissue
and cell culture supernatants
Stomach tissue extracts were prepared using a 2% saponin-PBS solution as previously
described [27]. Briefly, the stomach was excised and stored in a PBS solution containing 2 mM
phenylmethylsulfonylfluoride, 0.1 mg/ml of soybean trypsin inhibitor (Sigma), 0.05 mM
EDTA, 1% bovine serum albumin and 0.05% Tween. The tissue samples were thawed and then
permeabilized with saponin (Sigma) at a final concentration of 2% in PBS at 4°C over night.
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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Stomach tissue was then centrifuged at 13,000 × g for 10 min and the supernatants were ana-
lyzed for cytokines. Levels of IFN-γ and IL-17A in the extracted stomach tissue and cell culture
supernatant were analysed using the mouse cytometric bead array (CBA) flex set kit (BD Bio-
sciences) according to the manufacturer’s instructions.
Histology
Longitudinal strips from the entire stomach were taken, fixed in 4% phosphate-buffered forma-
lin and then embedded in paraffin. Sections 6-μm thick were cut and stained with haematoxy-
lin and eosin. The slides were then examined by light microscopy (100x), and the extent of
gastritis was graded as previously described [28]. The samples were “blinded” and given grades
for tissue damage and cellular infiltration as follows: Grade 0–1, normal gastric mucosa that
contained few lymphocytes scattered throughout the submucosa; Grade 2, small aggregates
containing three to four layers of cells in the mucosa or sparse infiltrates of cells in the submu-
cosa covering ~5% of the section; Grade 3, frequent and larger infiltrates extending into the
mucosa; Grade 4, infiltrates spanning half to the entire width of the mucosa; Grade 2–5, partial
or complete (grade 6) obliteration of parietal and chief cells with hyperplasia of mucous and
epithelial cells.
Cytokine staining and flow cytometric analysis
Spleen and MLNmononuclear cells were isolated and single-cell suspensions were prepared
and live cells counted under a microscope. For the spleen an extra cell lysing step was carried
out to remove the red blood cells (BD Biosciences). For cytokine staining, the cells were stimu-
lated with 20 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma) and 1 μg/ml ionomycin
(Sigma) in Iscove’s complete medium for 2 h at 37°C in a 5% CO2 atmosphere. After 2 h,
10 μg/ml Brefeldin A (Sigma) was added to the cells and left for an additional 2 h at 37°C in a
5% CO2 atmosphere. Surface or intracellular staining was performed using anti-mouse
CD3-PerCP, CD4-Alexa Fluor 700, CD8-v450, NK1.1-PE (all BD Biosciences), IL-17A-FITC
(eBioscience, San Diego, CA) and Live/Dead Fixable Aqua Dead Cell Stain Kit (Life Technolo-
gies, Carlsbad, CA). Stained cells were acquired using LSR-II Flow Cytometer and FACSDiva
software (BD Biosciences), and subsequent analyses were conducted using FlowJo software
(FlowJo, Treestar, Ashland, OR).
RNA isolation
The stomach was excised and dissected along the greater curvature. Any loose stomach con-
tents were removed by washing in PBS. One longitudinal strip including the corpus and
antrum were cut and placed directly into RNAlater and stored at -70°C. For RNA isolation, the
tissue was thawed and transferred to RLT lysis buffer and homogenized using a Tissue Lyser II.
Total RNA was extracted using RNeasy mini kit (Qiagen) and then stored at -70°C. RNA purity
and concentration was measured using the fluorospectrometer Nanodrop ND-1000.
cDNA preparation and real-time PCR array
RNA (2 μg) was reverse transcribed into cDNA using the Quantitect kit (Qiagen). Pooled
cDNA (2 μg) from individual mice in a group were run in a 96-well array plates (Mouse anti-
bacterial response array, SA Biosciences/Qiagen) according to manufacturer´s instruction
using the 7500 RT-PCR Applied Biosystems system. The difference between the sample gene
and the average from the housekeeping genes, β-actin, glyceraldehydes-3-phosphate dehydro-
genase (GAPDH), β-2 microglobulin (β2m), β-glucuronidase (Gusb) and heat shock protein
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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90 α b1 (Hsp90αb1) (ΔCT value) was obtained and the relative fold change was calculated
(2ΔCT). The 2ΔCT values for the vaccinated mice were compared to unvaccinated infected
mouse stomach tissue and expressed as fold-change compared to unvaccinated and infected
samples.
cDNA preparation and validation RT-PCR
Validation for the gene expression of Lipocalin 2 was carried out on individual cDNA samples
from all the groups using the RT² qPCR Primer Assay (Qiagen). The Real-time qPCR
(RT-PCR) were run in 96-well plates using the standard amplification conditions described for
the 7500 RT-PCR system and 40 ng cDNA, 10 μl 2× Power SYBR green master mix (Applied
Biosystems, Foster City, CA), and 1 μl of gene-specific oligonucleotide primers. The reactions
were run in duplicate, and β-actin was used as the reference gene in all experiments. The differ-
ence between β-actin and the target gene (ΔCT) was determined, and the relative expression
was calculated using the formula 2ΔCT. The values were adjusted so that the mean in the infec-
tion control group was set to 1. The negative control (lacking reverse transcriptase) giving the
lowest CT value was used to determine the detection limit.
Statistical analysis
Analyses were performed using an unpaired two-tailed t-test with Welch´s correction using
GraphPad Prism software version 6.0 (GraphPad Software Inc., San Diego, CA). A p value
of< 0.05 was considered significant.
Results
Sublingually immunized IFN-γ-/- mice are protected against H. pylori
infection mice
IFN-γ-/- and wild-type mice were immunized withH. pylori lysate antigens and CT via the SL
or IG route and then challenged with H. pylori. Two and five weeks after the challenge, the gas-
tric bacterial loads of the immunized and unimmunized IFN-γ-/- and wild-type mice were
determined.
IFN-γ-/- and wild-type mice immunized by the SL route had significant (25-fold and
56-fold, respectively, p< 0.001) reductions in their H. pylori bacterial loads compared with
unimmunized infected controls (Fig 1A). At 5 weeks post-challenge, the bacterial loads contin-
ued to remain significantly lower in sublingually immunized IFN-γ-/- and wild-type mice
(138-fold and 286-fold respectively, p< 0.001) compared with unimmunized mice (data not
shown).
The intragastrically immunized IFN-γ-/- mice and wild-type mice had smaller although sig-
nificant reductions in their H. pylori bacterial loads (4-fold, p< 0.05; and 16-fold, p< 0.01,
respectively) compared with unimmunized infected mice (Fig 1A). The IG route of immuniza-
tion tended to be less effective in reducing bacterial loads in the stomach of mice than the SL
route for both IFN-γ-/- and wild-type mice.
In general, the mean reduction in the bacterial load after SL or IG immunization was partly
affected by the lack of IFN-γ as immunized IFN-γ-/- mice had slightly higher gastric bacterial
loads compared with immunized wild-type mice, that was statistically significant in the case of
sublingually (p<0.05) but not intragastrically immunized mice (Fig 1A).
The bacterial load was not related to the serum antibody titres in the immunized mice as
both IFN-γ-/- and wild-type mice had comparable and significant increases in their serum IgG
antibody responses after both SL and IG immunization and challenge (p< 0.001 and
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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Fig 1. IFN-γ-/- and wild-typemice immunized by the SL or IG route have significantly reduced bacterial counts, generateH. pylori specific serum
IgG titers, and gastric IL-17A responses .Groups of IFN-γ-/- and wild-type (WT) were immunized via the SL or IG route with H. pylori lysate antigens and
CT (SL or IG) and then infected with live H. pylori bacteria. Unimmunized (Naïve) mice infected at the same time point served as controls (Inf). At 2 weeks
post infection mice were sacrificed and stomach tissue was sampled to determine the level of H. pylori colonization and gastric tissue cytokine levels. A.
mean cfu/g stomach for immunized and control WT and IFN-γ-/-mice B.Mean serum antibody titers ofH. pylori specific antibodies.C. IL-17A levels andD.
IFN-γ levels in stomach tissue extracts in pg/100 mg tissue. Data represent pool of two independent experiments of four with similar results, bars represent
mean values of n = 6–11 mice/group,. Statistical analysis was carried out using the unpaired two-tailed t-test with Welch’s correction, denoted by * (p<0.05),
** (p<0.01), *** (p<0.001). ND: Not Detected, ns: not significant.
doi:10.1371/journal.pone.0131444.g001
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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p< 0.001) compared with unimmunized infected mice (Fig 1B). In summary, wild- type and
IFN-γ-/- mice had significantly reduced bacterial loads after vaccination. Based on fold-change
in bacterial load, the SL immunization was more effective than IG immunization in both IFN-
γ-/- and wild-type mice.
Elevated gastric IL-17A responses in the stomach of immunized IFN-γ-/-
mice compared to immunized wild-type mice is associated with a lower
gastritis score
To correlate the local immune responses to the gastritis and protection in the vaccinated mice,
we studied the gastric IFN-γ and IL-17A responses of IFN-γ-/- and wild-type mice. Sublingually
immunized IFN-γ-/- mice showed significantly increased levels of IL-17A in the stomach tissue
extracts compared with immunized wild-type mice (3-fold, p< 0.05) (Fig 1C). Intragastrically
immunized IFN-γ-/- mice also had increased IL-17A levels in the stomach compared with
immunized wild-type mice, although this difference was not statistically significant (2-fold,
p = ns) (Fig 1C). IFN-γ was undetectable in the stomachs of IFN-γ-/- mice, irrespective of the
treatment (data not shown). In the stomachs of wild-type mice, IFN-γ levels were elevated in
sublingually (3-fold, p< 0.01) and intragastrically (5-fold, p = ns) immunized mice compared
with the unimmunized infected controls (Fig 1D).
We next evaluated the extent of post immunization gastritis in immunized IFN-γ-/- and
wild-type mice by grading the atrophy (destruction of parietal and chief cells) and infiltration
of immune cells in the corpus area of the stomach tissue. The gastric atrophy and infiltration in
the IFN-γ-/- and wild-type unimmunized infection controls were low and comparable between
the two groups (Fig 2A and 2B). When compared with their respective unimmunized infection
controls, sublingually immunized IFN-γ-/- and wild-type mice had significantly higher atrophy
scores (p< 0.01 and p< 0.001 respectively) (Fig 2A and 2C). Similar results were observed
when grading the tissue for infiltration in sublingually immunized IFN-γ-/- mice (p< 0.05)
and immunized wild-type mice (p< 0.001) when compared with their respective unimmu-
nized infection controls (Fig 2B and 2C). However, sublingually immunized IFN-γ-/- mice had
significantly lower atrophy and infiltration (p< 0.01) compared with sublingually immunized
wild-type mice (Fig 2A, 2B and 2C). Finally, intragastrically immunized IFN-γ-/- and wild type
mice had significantly lower atrophy and infiltration scores in the stomach post-challenge
compared to sublingually immunized IFN-γ-/- and wild type (Fig 2A, 2B and 2C). We found
no significant difference in the gastritis scores between intragastrically immunized IFN-γ-/- and
wild type mice. In summary, the elevated IL-17A responses in the stomach of sublingually
immunized IFN-γ-/- mice had minor influence on the gastritis (atrophy and infiltration) scores
compared to sublingually immunized wild-type mice.
In vitro proliferative response to H. pylori antigens and IL-17A secretion
is intact in immunized IFNγ-/- mice
To study the possible effects of lack of IFN-γ on CD4+ T cell priming and Th1 and Th17 polar-
ization we prepared single-cell suspensions of spleen cells from sublingually or intragastrically
immunized IFN-γ-/- and wild-type mice and also unimmunized infected mice. Cells were cul-
tured in vitro in the presence ofH. pylori lysate antigens, and the proliferative response and
cytokine secretion analyzed. There was a significant difference in the capacity of the cells from
immunized IFN-γ-/- or wild-type mice to respond to H. pylori antigens compared to unimmu-
nized infection controls (Fig 3A). There was even a tendency for higher proliferative response
from cells isolated from immunized IFNγ-/- compared to WT mice which was significant in
sublingually immunized mice (p<0.01). The IL-17A and IFN-γ secretion in the culture
IL-17A Responses to H. pylori in IFN-γ-/- Mice
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Fig 2. Intragastrically or sublingually immunized IFN-γ-/- and wild-typemice have higher Inflammation and atrophy scores.Groups of IFN-γ-/- and
wild-type (WT) were immunized via the SL or IG route with H. pylori lysate antigens and CT (SL or IG) and infected with live H. pylori bacteria. Unimmunized
(Naïve) mice infected at the same time point served as infected controls (Inf). At 2 weeks post-infection the mice were sacrificed. Stomach tissue was
sampled to determine the score the inflammation. A. Atrophy andB. Infiltration scores of formalin fixed stomach tissue stained with hematoxylin and eosin.
Data represent pool of two independent experiments of three with similar results, bars represent mean values of n = 6–11 mice/group. Gastritis scores from
immunized mice were compared to their respective infected controls and was assessed with the unpaired two-tailed t-test with Welch’s correction and
denoted by * (p<0.05), ** (p<0.01), *** (p<0.001).C.Microscopy images (100x) of hematoxylin and eosin stained sections of a representative corpus area
of stomach from unimmunized infected (Inf), SL and IG immunized IFNγ-/-mice (top row) and wild-type mice (bottom row).
doi:10.1371/journal.pone.0131444.g002
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supernatant from spleen cells was analyzed and found to be elevated in immunized compared
to unimmunized infection controls (Fig 3B and 3C). The secretion of IL-17A from cells isolated
Fig 3. Splenocytes from both intragastrically and sublingually immunized IFN-γ-/- mice and wild-typemice have increased in vitro proliferative
responses, and cytokine secretion.Groups of IFNγ-/- and wild-type (WT) mice were sublingually (SL) or intragastrically (IG) immunized with H. pylori lysate
antigens and CT or left unimmunized (Inf) and then challenged with live H. pylori bacteria. Mice were sacrificed and spleen cells were isolatedA. Single cell
suspensions were prepared and cultured in 6 replicate wells together with H. pylori lysate antigens. Counts per minute (cpm) of incorporated radioactive
thymidine were used as a measure of proliferation of the cells. Each dot represents an individual mouse and the bars the mean of the group. Representative
data of one of three independent experiments. Supernatants were collected from in vitro cultured spleen cells (from A) and assessed for cytokinesB. IL-17A
andC. IFN-γ. Values are shown in pg/ml. Levels in immunized mice were compared to their respective infection controls and was assessed with the unpaired
two-tailed t-test with Welch’s correction and denoted by * (p<0.05), ** (p<0.01), *** (p<0.001). ND: Not Detected, ns: not significant
doi:10.1371/journal.pone.0131444.g003
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from immunized IFN-γ-/- and wild-type mice was comparable (Fig 3B). In summary, our
results demonstrate that irrespective of the immunization route (SL or IG) the vaccine-induced
proliferative and IL-17A responses to H. pylori antigens are intact in the absence of IFNγ.
The CD3+CD4+ T cells are source of IL-17A production in the spleen and
MLN of immunized IFN-γ-/- and wild-type mice
We next addressed by flow cytometry, the source of IL-17A secretion by spleen and MLN cells
isolated from immunized or unimmunized mice 3 weeks post-challenge. Cell suspensions were
prepared and stimulated in vitro and subsequently stained for cell surface markers and intracel-
lular IL-17A and IFN-γ. There was no significant difference in the proportion of IL-17A secret-
ing cells detected in either the spleen or the MLN in either IFN-γ-/- or wild-type mice, except
that IG vaccination appeared to induce higher frequency of IL-17A+ cells in both organs (Fig
4A and 4B). The primary producers of IL-17A in infected or immunized mice were CD3+CD4+
cells, while the source of IFN-γ in immunized wild-type mice post-infection was the CD3+-
CD4- cells and to a lesser extent by the CD3+CD4+ population (Fig 4A and data not shown). In
summary, we have identified the CD3+CD4+ cells to be main population of cells secreting IL-
17A in the spleen and MLN duringH. pylori infection, while CD3+CD4- cells to be the main
producers of IFN-γ.
Neutralization of IL-17A in sublingually immunized IFN-γ-/- mice
abrogated the protection, anti-microbial response and proliferation by
MLN cells in response to H. pylori antigens
Since our results until now suggested that bacterial reduction can be induced in IFN-γ-/- mice
after immunization with enhanced IL-17A secretion, we were therefore interested in studying
the effects of removal of IL-17A during the effector phase, after sublingual immunization and
infection in IFN-γ-/- mice. We report that, neutralization of IL-17A in sublingually immunized
IFN-γ-/- mice post-infection resulted in a significant (p< 0.001) increase in the bacterial load
compared with sublingually immunized mice injected the isotype control IgG antibody (Fig
5A). Stomach tissue extracts were further analyzed to evaluate the efficiency of in vivo neutrali-
zation of IL-17A. A two-fold reduction in IL-17A protein levels was observed in the stomachs
of immunized mice receiving neutralizing IL-17A antibody compared with mice administered
the isotype control IgG antibody (Fig 5B). The effect of IL-17A neutralization on the gastritis
(atrophy and infiltration) in sublingually immunized IFN-γ-/- mice was also evaluated and
found to be significantly lower than that in sublingually immunized IFN-γ-/- mice receiving the
isotype control IgG antibody (Fig 5C and 5D).
To investigate the effect of neutralizing IL-17A on cellular immune responses, single cell
suspensions fromMLN were prepared and stimulated in vitro with H. pylori antigens. MLN
cells from sublingually immunized mice administered an isotype control IgG antibody showed
enhanced proliferation toH. pylori antigens compared with those from unimmunized infected
mice (Fig 5E). Remarkably, in sublingually immunized IFN-γ-/- mice receiving neutralizing
antibodies to IL-17A, the MLN cell proliferation was reduced to the level of unimmunized
infected mice administered isotype control IgG antibody (Fig 5E). MLN cells were also
evaluated for their secretion of cytokines in cell culture supernatants. An impaired secretion of
IL-17A in sublingually immunized mice receiving neutralizing IL-17A compared with sublin-
gually immunized mice receiving the isotype control was observed (Fig 5F).
To further understand the mechanisms whereby sublingually immunized IFN-γ-/- mice
could control their bacterial colonization and the role of IL-17A in this process, we carried out
real-time PCR array (antibacterial response) analysis of the stomach tissue from IFN-γ-/- mice
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administered anti-IL-17A antibody or isotype control. Reduced expression of antimicrobial
peptide related genes, Camp (Cathelicidin), Lcn2 (Lipocalin 2) and Ltf (Lactotransferrin) was
seen in the stomach tissue of sublingually immunized IFN-γ-/- mice administered anti-IL-17A
compared to immunized mice administered isotype control antibody (Table 1A). In addition,
cytokine IL-6, chemokines (Cxcl1, Cxcl3) and inflammasome pathway related genes (Casp1
and Nlrp1) were less expressed in stomach tissue after IL-17A neutralization compared to mice
administered isotype control antibody after sublingual vaccination (Table 1B and 1C). Finally,
validation PCRs in individual mice showed that Lcn2 expression was significantly lower in the
stomach of immunized mice administered anti-IL-17A compared to immunized mice adminis-
tered isotype control antibody (Fig 5G) with a tendency also for lower expression of Ltf and
Defb3 (mouse β-defensin-3) (data not shown).
Taken together, the in vivo administration of neutralizing IL-17A antibody after SL immu-
nization and challenge in IFN-γ-/- mice resulted in (i) abolished protection againstH. pylori
infection, (ii) dampened gastric inflammation, (iii) reduced expression of antimicrobial
response genes and (iv) impaired MLN cell proliferation and IL-17A secretion in response to
H. pylori antigens.
Discussion
Protection againstH. pylori infection has been shown to be associated with post-immunization
gastritis, and an increase in both IFN-γ and IL-17A in the stomachs of immunized mice [17].
The aim of the current study was to determine whether protection could be separated from
post-immunization gastritis after SL immunization by studying the role of IFN-γ and IL-17A
in these two processes. We report that the protection against H. pylori infection after SL with
H. pylori lysate antigens and cholera toxin can be induced in the absence of IFN-γ although to
somewhat lower levels compared to immunized WT mice. Furthermore, the sublingually
immunized IFN-γ-/- mice had significantly elevated IL-17A levels in the stomach tissue com-
pared with immunized wild-type mice. Indeed, in vivo neutralization of IL-17A in sublingually
immunized IFN-γ-/- mice abrogated the protection and anti-microbial response against H.
pylori infection.
Different mucosal routes of immunization have rarely been compared in the same study
when evaluating candidate vaccine preparations against H. pylori infection. One could
hypothesise that differences in the environment and the stability of the antigens and adjuvant
at the two sites (SL/IN versus IG) may contribute to differences in the induction of immune
responses and, consequently, protection against H. pylori infection. Indeed, we have demon-
strated using the same dose of the vaccine, that in mice immunized with recombinant HpaA
and UreB and CT [29] or H. pylori lysate antigens and dmLT [25], the protection against H.
pylori was significantly better in sublingually than in intragastrically immunized mice. Further-
more, we have preliminary data showing a higher frequency of IFN-γ+ and IL-17A+ cells in the
draining cervical lymph nodes after SL immunization withH. pylori antigens and CT than in
the MLN after IG immunization (Sjökvist-Ottsjö et al.manuscript in preparation), suggesting
that, when using CT as an adjuvant, the route of immunization may affect T cell priming and
Fig 4. IL-17A and IFN-γ production from Spleen and MLN cells of intragastrically or sublingually immunized IFN-γ-/- and wild-typemice.Groups of
IFN-γ-/- and wild-type (WT) were immunized via the SL or IG route with H. pylori lysate antigens and CT (SL or IG) or left unimmunized (Inf) and then
challenged with live H. pylori bacteria. At three weeks post challenge mice were sacrificed and spleen and MLN was taken for flow cytometric analysis.
Spleen and MLN was taken from individual mice (n = 4) and single cell single cell suspensions were prepared and stimulated in vitro with PMA and Ionomycin
and then stained for further flow cytometric analysis.AGating strategy showing analysis of IL-17A and IFN-γ secreting cells among live CD3+ T cells.B Bar
graph shows frequency mean + SD of IL-17A+ cells in spleen and MLN. Data represent one of two independent experiments.
doi:10.1371/journal.pone.0131444.g004
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cytokine production and subsequently protection againstH. pylori infection. Other possibilities
that require further investigation when immunizing via the intragastric route include the dose,
timing and number of immunizations, which may also have an influence on the immune
response and protection againstH. pylori [30].
In the stomachs of sublingually immunized IFN-γ-/- mice, the IL-17A levels were elevated
with significantly lower atrophy and infiltration scores compared with sublingually immunized
wild-type mice. In agreement with our results, a recent study by Ding et al. demonstrated that
intranasally immunized IL-12p35-/- mice (deficient in IFN-γ responses) were as well protected
against H. pylori infection as wild-type mice, and showed increased gastric IL-17A gene expres-
sion in the stomach [31]. These data suggest that in the absence of inhibitory signals from Th1
cytokines, IL-17A responses dominate [32] and contribute to the reduction in the gastric bacte-
rial loads of immunized mice. We also observed elevated IL-17A in the stomach tissue of intra-
gastrically immunized IFN-γ-/- mice and that these mice were less protected againstH. pylori
infection compared with sublingually immunized IFN-γ-/- mice. One key difference in the gas-
tric immune response between the intragastrically and sublingually immunized IFN-γ-/- mice
was the inflammation score. The sublingually immunized IFN-γ-/- mice had a significantly
higher inflammation scores than intragastrically immunized IFN-γ-/- mice. Thus, our data sug-
gests that the mechanism by which mice are protected against H. pylori infection involves IL-
17A and additional as-yet-unknown accessory cells that are more effectively recruited to the
stomach by SL than IG immunization. Therefore, future studies should address in detail the
phenotype of the immune cell populations that migrate into the stomachs of sublingually or
intragastrically immunized IFN-γ-/- mice and secrete IL-17A in response toH. pylori infection.
Previous studies in wild-type mice have shown that the vaccine-induced protection against
H. pylori infection was associated with post-immunization gastritis [5, 9, 33, 34]. And there has
been one report of post-immunization gastritis, in human volunteers that were vaccinated
against H. pylori and then challenged [35]. The gastritis in mice is characterized by the infiltra-
tion of CD4+ T cells, B cells, neutrophils, mast cells and eosinophils that secrete cytokines or
mediators, presumably making the environment unfavourable for the colonization of H. pylori
[5, 8]. Sublingually immunized IFN-γ-/- mice were able to significantly reduce colonization, but
also had significantly decreased the inflammation scores compared to immunized wild type
mice. In keeping with our observations, liposome-mediated depletion of macrophages has been
shown to reduce the gastric pathology of H. pylori-infected mice, but did not affect the protec-
tion [36]. Further, the recent study by Ding et al has shown that the treatment ofHelicobacter-
infected mice with recombinant IL-12 (which induces IFN-γ production by T cells) results in
enhanced gastritis and reduced bacterial loads compared with untreated mice [31]. Unfortu-
nately, the frequency or activation of macrophages was not addressed in that study. Our data
Fig 5. Neutralization of IL-17A abrogates protection, and reduces gastric inflammation and proliferation of MLN cells in sublingually immunized
IFN-γ-/- mice. IFN-γ-/-mice were sublingually immunized withH. pylori lysate antigens and CT (SL) or left unimmunized (Inf) and infected with liveH. pylori
bacteria. Mice were injected intraperitoneally neutralizing IL-17A antibody (αIL-17A) or control IgG antibody (IgG). Two weeks post infection mice were
sacrificed.A. Stomach tissue was analyzed for H. pylori colonization by quantitative culture and expressed as mean log10 cfu per stomach, and SEM.B.
analysis of IL-17A secretion in stomach tissue extracts andC. Atrophy andD. Infiltration in stomach tissue was scored. n = 6–11 mice/group, pool of two
experiments. Bars represent mean. Statistically significant difference between sublingually immunized IFN-γ-/-mice injected neutralizing IL-17A antibody
compared to immunized mice injected isotype control antibody was calculated by an unpaired two-tailed t-test with Welch correction and denoted by
* (p<0.05), ** (p<0.01), *** (p<0.001). F. single cell suspensions of MLN were prepared and cultured in vitrowithH. pylori lysate antigens. Counts per minute
(cpm) of incorporated radioactive thymidine was used as a measure of proliferation of the cells. Bars represent mean value and standard deviation (SD) counts
in 6 individual wells in pooled mice (n = 5–7 mice/group)G. Supernatants were collected from in vitro cultured MLN (from D) and assessed for IL-17A shown in
pg/ml, of six pooled wells. Data pool of two independent experiments. E. Stomach tissue was analyzed for gene expression of Lcn (Lipocalin-2) and expressed
as relative gene expression where unimmunized infection control was set to 1. Statistically significant difference between sublingually immunized IFN-γ-/-mice
injected neutralizing IL-17A antibody compared to immunized mice injected isotype control antibody was calculated by an unpaired two-tailed t-test with
Welch’s correction and denoted by *** (p<0.001).
doi:10.1371/journal.pone.0131444.g005
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suggest that the elevated levels of gastric IFN-γ in H. pylori-infected and vaccinated mice is
pro-inflammatory, potentially through the activation of M1 macrophages we have previously
shown to be accumulated in the stomach of vaccinated mice post-infection [37].
Our observation that the neutralization of IL-17A in immunized IFN-γ-/- mice abrogated
the protection againstH. pylori infection is consistent with previous reports on the role of IL-
17A in reducing bacterial load in the stomach of mice [17, 18]. We further report that MLN
cells, isolated from sublingually immunized IFN-γ-/- mice injected with IL-17A neutralizing
antibody, showed a dampened in vitro proliferative response toH. pylori antigens. These
Table 1. Relative Gene expression in stomach tissue after SL vaccination and IL-17A neutralization
compared to non-immunized controls.
A Antimicrobial peptides
H. pylori Lysate + CT
Gene IgG αIL-17A
Camp (Cathelicidin) 4.83 2.60
Ctsg (Cathepsin G) 0.37 0.35
Lcn2 (Lipocalin 2) 5.43 0.53
Lcf (Lactotransferrin) 9.16 2.01
Lyz2 (Lysozyme 2) 0.86 0.52
Mpo (Myeloperoxidase) 1.47 0.39
Prtn3 (Proteinase 3) 1.06 0.38
Slpi (Secretory leukocyte peptidase inhibitor) 1.52 1.56
B Cytokines and Chemokines
H. pylori Lysate + CT
Gene IgG αIL-17A
Ccl3 (MIP-1α) 0.50 0.54
Ccl4 (MIP-1β) 1.52 1.05
Ccl5 (RANTES) 0.83 0.66
Cxcl1 (Groα/MIP-2/KC) 3.88 0.61







H. pylori Lysate + CT
Gene IgG αIL-17A
Casp1 (Caspase 1) 3.64 1.10
Naip1 (NAIP-1) 1.94 0.37
Nlrc4 (NLRC-4) 1.14 0.31
Nlrp1a (NALP-1A) 2.18 1.75
Nlrp3 (NALP-3) 1.51 0.41
Pycard (PYD and CARD domain containing) 1.17 0.70
§ RT-PCR array on stomach tissue. The difference between housekeeping gene β-actin and the target
gene (ΔCT) was determined, and the relative expression was calculated using the formula 2ΔCT. Values are
then expressed as fold change in gene expression in vaccinated mice compared to stomach tissue taken
from unvaccinated infected mice.
doi:10.1371/journal.pone.0131444.t001
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findings suggest that whereas SL immunization likely expands a pool of H. pylori-specific T
cells that secrete IL-17A, the challenge further expands this pool of IL-17A-secreting cells
(which was blocked by the neutralizing antibody), followed by their migration to the stomachs
of infected mice and the consequent reduction in bacterial numbers. Thus, while IL-17A seems
to be dispensable during the priming phase of the immune response, it is critical during the
effector phase through effect on neighbouring cells (see below) and can remarkably reduce the
bacterial load in the stomach of vaccinated mice with minimal inflammation.
IL-17A has been shown to have a protective role in other mucosal infections including
Citrobacter rodentium, an extracellular Gram-negative gut bacterium that naturally infects
mouse colonies. The generation of protective Th17 responses in C. rodentium infection had
been found to be IL-23 dependent. Additionally, IL-22 may contribute to early host defence
through the induction of antimicrobial peptides in colonic epithelial cells. As proposed by sev-
eral reports and now also supported by our results, Th17 cytokines may have a protective func-
tion for the effective host defence against extracellular pathogens at mucosal sites [38, 39].
These results are not surprising, considering some of the known functions of IL-17A: the secre-
tion of IgA, recruitment of neutrophils and upregulation of anti-microbial peptides by epithe-
lial cells [40].
Indeed, we observed that IL-17A neutralization in sublingually immunized IFN-γ-/- mice
led to a decrease in gene expression of cathelicidin, lactotransferrin and lipocalin 2, suggesting
that anti-microbial peptides and iron chelating proteins maybe an important component of the
local anti-microbial response in againstH. pylori infection affected by IL-17A. In keeping with
these results, expression of Lcn2 was also increased compared to unimmunised controls in
mice immunised using a recombinant attenuated salmonella-based H. pylori vaccine [39]. Sev-
eral studies have also shown an inhibitory effect of antimicrobial peptides, lactotransferrin and
lipocalin-2 onH. pylori growth in vitro [41–43]. Our data suggests that the lack of protection
seen after IL-17A neutralization in IFN-γ-/- mice is partly due to a dampened antimicrobial
response.
In conclusion, we report protection againstH. pylori infection in IFN-γ-/- mice after SL and
IG immunization, although to a lesser extent than wild-type mice. The reduction in the gastric
bacterial loads of sublingually immunized IFN-γ-/- mice was associated with elevated IL-17A
responses, and reduced post-immunization gastritis compared with sublingually immunized
wild-type mice. The neutralization of IL-17A in IFN-γ-/- mice abolished the protection against
H. pylori infection. Our results suggest that the post-immunization gastritis of sublingually
immunized mice may be promoted by CD3+CD4- derived IFN-γ (and possibly other pro-
inflammatory cytokines), whereas CD3+CD4+ derived IL-17A appears to be specific to the
anti-bacterial response toH. pylori infection. The importance of IL-17A for protection against
H. pylori infection will have implications for the design of anti-H. pylori vaccines as the compo-
sition, formulation and the route of immunization may influence the induction of appropriate
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